These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7952982)

  • 1. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder.
    Clark DM; Salkovskis PM; Hackmann A; Middleton H; Anastasiades P; Gelder M
    Br J Psychiatry; 1994 Jun; 164(6):759-69. PubMed ID: 7952982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia.
    Ost LG; Westling BE; Hellström K
    Behav Res Ther; 1993 May; 31(4):383-94. PubMed ID: 8099789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder.
    Ost LG; Westling BE
    Behav Res Ther; 1995 Feb; 33(2):145-58. PubMed ID: 7887873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological treatments of panic disorder without agoraphobia: cognitive therapy versus applied relaxation.
    Arntz A; van den Hout M
    Behav Res Ther; 1996 Feb; 34(2):113-21. PubMed ID: 8741719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
    Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
    J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming resistance to exposure in panic disorder with agoraphobia.
    Fava GA; Savron G; Zielezny M; Grandi S; Rafanelli C; Conti S
    Acta Psychiatr Scand; 1997 Apr; 95(4):306-12. PubMed ID: 9150824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder.
    Shear MK; Pilkonis PA; Cloitre M; Leon AC
    Arch Gen Psychiatry; 1994 May; 51(5):395-401. PubMed ID: 8179463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior therapy, supportive psychotherapy, imipramine, and phobias.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1978 Mar; 35(3):307-16. PubMed ID: 31847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
    Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of panic disorder treatments on personality disorder characteristics.
    Hofmann SG; Shear MK; Barlow DH; Gorman JM; Hershberger D; Patterson M; Woods SW
    Depress Anxiety; 1998; 8(1):14-20. PubMed ID: 9750974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
    Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
    Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined behavioral therapy and pharmacotherapy of agoraphobia.
    Mavissakalian M
    J Psychiatr Res; 1993; 27 Suppl 1():179-91. PubMed ID: 7908332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical recovery from panic disorder is associated with evidence of changes in cardiovascular regulation.
    Middleton HC; Ashby M
    Acta Psychiatr Scand; 1995 Feb; 91(2):108-13. PubMed ID: 7778467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotion-focused psychotherapy for patients with panic disorder.
    Shear MK; Houck P; Greeno C; Masters S
    Am J Psychiatry; 2001 Dec; 158(12):1993-8. PubMed ID: 11729015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive treatment for panic disorder.
    Gelder MG; Clark DM; Salkovskis P
    J Psychiatr Res; 1993; 27 Suppl 1():171-8. PubMed ID: 8145177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.